Biographies

Jose A. Cancelas Perez, MD, PhD

Division Director of Research, Hoxworth Blood Center

Deputy Director, Hoxworth Blood Center

Director, Research Flow Cytometry Core

Leader, Stem Cell Program

Medical Director of Cellular Therapies, Hoxworth Blood Center

Professor, UC Department of Pediatrics

Phone: 513-558-1324

Fax: 513-558-1522

Email: jose.cancelas@uc.edu

Show All

Specialties

Hematopoietic stem cell proliferation and differentiation

Visit the Cancelas Lab.
 

Education and Training

MD: Autonomous University of Madrid, Spain, 1989.

Residency: Hematology and Hematotherapy, University of Alcala de Henares, Madrid, Spain, 1993.

PhD: Faculty of Medicine, University of Alcala de Henares, Madrid, Spain, 1996.

Publications

View PubMed Publications

Grants

Progenitor Cell Biology Consortium Administrative Coordinating Center, NHLBI/ Subaward through Univ. Maryland. Co-Director. (Cincinnati Cell Char Core). Sep 2010 – Aug 2016. #U01 HL099997. 

Rational Design of a Vav/Rac Inhibitor as a New Therapy for High-Risk B-ALL. Principal Investigator. Leukemia & Lymphoma Society of North America. Oct 2012 – Sep 2015. 

Cincinnati Excellence in Molecular Hematology: Cell Analysis and Sorting Core, NIH/NIDDK. Co-investigator. (Flow Cytometry Core Co-PI).  Sep 2010 – Jun 2015. #P30DK090971-01.

Rac GTPase Inhibition in Chronic Myelogenous Leukemia. Principal Investigator. National Institutes of Health. Apr 2009 – Feb 2014. #R01 HL 087159.

Improving Hematopoietic Stem Cell Mobilization by the EGFR inhibitor Erlotinib. Co-Principal Investigator with Hartmut Geiger. NIH/NHLBI. Feb 2011 – Jan 2013. #R43HL108403-01.

Connexin-43 in Bone Marrow Failure After Cancer-Related Chemotherapy. Principal Investigator. Heimlich Institute. Apr 2010 – Mar 2013.